Sandu Pharmaceuticals Ltd

NSE: SANDUPHQ · BSE: 524703 · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹36.82
Market cap: ₹35.57 Cr
Revenue (annual): ₹69.93 Cr
Net profit (annual): ₹1.77 Cr
P/E (TTM): 14.6×Sector 47.3×
Promoter holding: 37.79%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 6 Financial Results 3 Board Meeting Date 3 Management Change 2 Annual General Meeting 2 Legal & Regulatory 1 Fund Raise 1 Dividend 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

5 May 2026 18:22 IST BSE

Fund Raise

Sandu Pharmaceuticals Fund Raise of ₹5.34 Cr

Sandu Pharmaceuticals Ltd reported zero deviation in the utilization of ₹5.34 Crore raised across three tranches of preferential issues. Funds were deployed for plant revamping, machinery upgrades, and working capital. The company confirmed all proceeds for the first two tranches were fully utilized as of March 31, 2026.

Value: ₹5.34 Cr

Read the filing ↗